Literature DB >> 11703096

Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.

M Terada1, A Shimizu, N Sato, S I Miyakaze, H Katayama, M Kurokawa-Seo.   

Abstract

The fibroblast growth factor receptors (FGFRs) are a family of transmembrane tyrosine kinases that play a key role in cell growth and tumorigenesis in response to FGFs. FGFR complexity is increased by the existence of additional isoforms generated by alternative mRNA splicing. We identified that the transcript FGFR3DeltaTM, an alternatively spliced isoform of FGFR3 lacking exons encoding the C-terminal half of Ig III (IIIb) and transmembrane domains, is expressed in the human squamous carcinoma cell line DJM-1. To determine whether FGFR3DeltaTM has the potential to be secreted, we analyzed the protein expression in CHOK1 cells transfected with FGFR3DeltaTM cDNA and DJM-1 cells. Western blot analysis revealed that FGFR3DeltaTM protein was secreted, N-glycosylated, and dimerized by an intermolecular disulfide bond. Cross-linking experiments showed that FGF1 and FGF2 were able to bind to FGFR3DeltaTM, suggesting that the loss of the Ig IIIb domain may confer upon FGFR3DeltaTM the ability to bind to FGF2. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703096     DOI: 10.1006/mcbr.2001.0306

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  5 in total

1.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.

Authors:  Jay W Shin; Michael Min; Fréderic Larrieu-Lahargue; Xavier Canron; Rainer Kunstfeld; Lynh Nguyen; Janet E Henderson; Andreas Bikfalvi; Michael Detmar; Young-Kwon Hong
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 2.  Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.

Authors:  Margaret A Knowles
Journal:  World J Urol       Date:  2007-10-03       Impact factor: 4.226

3.  A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.

Authors:  Erica di Martino; Darren C Tomlinson; Margaret A Knowles
Journal:  Adv Urol       Date:  2012-07-31

Review 4.  The Fibroblast Growth Factor signaling pathway.

Authors:  David M Ornitz; Nobuyuki Itoh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-13       Impact factor: 5.814

Review 5.  Current Care and Investigational Therapies in Achondroplasia.

Authors:  Sheila Unger; Luisa Bonafé; Elvire Gouze
Journal:  Curr Osteoporos Rep       Date:  2017-04       Impact factor: 5.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.